Inhibition of Geranyl-Geranyl Prenylation by Statins: A Novel Model of Disease Modification of Systemic Sclerosis

Author(s): Chris T. Derk.

Journal Name: Letters in Drug Design & Discovery

Volume 3 , Issue 3 , 2006

Become EABM
Become Reviewer


Statins display numerous effects independent of their well described lipid-lowering effect that may be of potential benefit in preventing vascular injury and ischemic vascular events. These effects may both prevent and improve vessel wall abnormalities. We review the current literature to provide support that statins may have a modifying effect on the vasculopathy, fibrosis and immune dysregulation observed in systemic sclerosis.

Keywords: Systemic sclerosis, scleroderma, statins, vasculopathy, tissue fibrosis

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Page: [183 - 187]
Pages: 5
DOI: 10.2174/157018006776286998
Price: $58